Taro Provides Results for Quarter Ended June 2018
Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO)
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-irhome
Company Research
Source: Business Wire
HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2018. Quarter ended June 30, 2018 Highlights - compared to June 30, 2017 Net sales of $154.6 million, decreased $6.7 million, or 4.2%, the result of continuing increased competition and the challenging pricing environment; despite an overall increase in volumes of 11.1%. Gross profit of $100.1 million, decreased $16.5 million and as a percentage of net sales, was 64.7% compared to 72.2%. Research and development expenses of $13.3 million decreased $1.3 million. Selling, marketing, general and administrative expenses of $23.6 million decreased $0.7 million. Operating income of $63.2 million decreased $14.5 million and as a percentage of n
Show less
Read more
Impact Snapshot
Event Time:
TARO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TARO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TARO alerts
High impacting Taro Pharmaceutical Industries Ltd. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TARO
News
- TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TAROBusiness Wire
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. [Yahoo! Finance]Yahoo! Finance
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.Business Wire
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
TARO
Earnings
- 1/25/24 - Beat
TARO
Sec Filings
- 4/15/24 - Form SC
- 3/20/24 - Form SC
- 3/11/24 - Form SC
- TARO's page on the SEC website